A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group Trial Evaluating the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults w/ADHD
Clinical Trial Grant
Administered By
Psychiatry, Child & Family Mental Health & Community Psychiatry
Awarded By
Otsuka American Pharmaceutical, Inc
Start Date
June 1, 2018
End Date
February 27, 2021
Administered By
Psychiatry, Child & Family Mental Health & Community Psychiatry
Awarded By
Otsuka American Pharmaceutical, Inc
Start Date
June 1, 2018
End Date
February 27, 2021